RecruitingNCT07363278
A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System
Sponsor
Seoul National University Hospital
Enrollment
40 participants
Start Date
Dec 26, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Study Type: Observational Study Goal: The goal of this study is to evaluate the incidence and burden of silent cerebral lesions (SCLs) detected on brain magnetic resonance imaging (MRI) after pulsed field ablation (PFA) for atrial fibrillation (AF). PFA is a new non-thermal ablation technique that selectively targets cardiac tissue while minimizing damage to surrounding structures. The study focuses on adult patients with paroxysmal or persistent AF who undergo left-atrial ablation using the VARIPULSE PFA system.
Eligibility
Min Age: 19 Years
Inclusion Criteria1
- \) Patients undergoing atrial fibrillation ablation using the Varipulse™ catheter
Exclusion Criteria11
- Individuals under 19 years of age
- Patients who undergo concomitant radiofrequency ablation of the left atrium during the procedure
- Patients with a history of stroke or transient ischemic attack (TIA)
- Patients who have previously undergone ablation or surgery for atrial fibrillation
- Patients with intracardiac thrombus or embolic events within the past 90 days
- Patients who have experienced cardiac surgery or acute coronary syndrome within the past 90 days
- Patients with contraindications to oral anticoagulant therapy, or those who require temporary discontinuation of anticoagulation due to procedural complications (e.g., cardiac tamponade)
- Patients with a left ventricular ejection fraction (LVEF) of less than 35%
- Women who are currently pregnant or planning to become pregnant during the study period
- Patients with a life expectancy of less than one year
- Patients at increased risk during MRI scanning (e.g., those with pacemakers or other metallic implants affected by MRI, or those with severe claustrophobia)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07363278
Related Trials
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT0678446626 locations
COCONUT Study Concomitant PVI and LAAC
NCT068616731 location
LA Function After PFA in Paroxysmal AF
NCT074390161 location
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT0717542837 locations
Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
NCT071307731 location